Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Galectin Therapeutics
GALT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.77
0
0.00%
Pre-Market: Sep 20, 4:04 PM EDT
15 minutes delayed
Get Report
Comment
Galectin Therapeutics (GALT) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Galectin Therapeutics (NASDAQ:GALT) Stock
Galectin Therapeutics Stock (NASDAQ: GALT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, August 16, 2024
HC Wainwright & Co. Reiterates Buy on Galecti...
Benzinga Newsdesk
Tuesday, August 13, 2024
Galectin Therapeutics Q2 EPS $(0.20) Misses $...
Benzinga Newsdesk
Wednesday, July 24, 2024
Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Avi Kapoor
Wednesday, May 15, 2024
As Of March 31, 2024, Galectin Therapeutics H...
Benzinga Newsdesk
Galectin Therapeutics Q1 2024 GAAP EPS $(0.19...
Benzinga Newsdesk
Tuesday, April 23, 2024
Galectin Therapeutics And 2 Other Penny Stocks Insiders Are Buying
Avi Kapoor
Tuesday, April 09, 2024
HC Wainwright & Co. Reiterates Buy on Galecti...
Benzinga Newsdesk
Galectin Therapeutics Highlights Outcome Of F...
Benzinga Newsdesk
Friday, April 05, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Monday, April 01, 2024
HC Wainwright & Co. Reiterates Buy on Galecti...
Benzinga Newsdesk
Monday, November 13, 2023
Galectin Therapeutics: Q3 Earnings Insights
Benzinga Insights
Galectin Therapeutics' $20.4M Of Cash And Cas...
Benzinga Newsdesk
Galectin Therapeutics Q3 EPS $(0.24) Misses $...
Benzinga Newsdesk
Tuesday, October 03, 2023
Galectin Therapeutics Reports The Outcome Of ...
Benzinga Newsdesk
Tuesday, September 26, 2023
Galectin Therapeutics To Present Update On It...
Benzinga Newsdesk
Tuesday, August 15, 2023
HC Wainwright & Co. Reiterates Buy on Galecti...
Benzinga Newsdesk
Monday, August 14, 2023
Galectin Therapeutics Q2 EPS $(0.15) Beats $(0.21) Estimate
Happy Mohamed
Friday, July 21, 2023
Galectin Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
Lisa Levin
Wednesday, May 17, 2023
HC Wainwright & Co. Reiterates Buy on Galecti...
Benzinga Newsdesk
Monday, May 15, 2023
Galectin Therapeutics Q1 EPS $(0.19) Beats $(...
Benzinga Newsdesk
Thursday, March 30, 2023
Galectin Therapeutics Reports FY22 EPS Loss O...
Benzinga Newsdesk
Thursday, March 16, 2023
Galectin Therapeutics Reported The Outcome Of...
Benzinga Newsdesk
Friday, March 03, 2023
HC Wainwright & Co. Reiterates Buy on Galecti...
Benzinga Newsdesk
Thursday, March 02, 2023
Galectin Therapeutics Provides Final Randomization Status Of NAVIGATE, Its Seamless, Adaptive Phase 2b/3 Study of Belapectin In Patients With Liver Cirrhosis Caused By Non-Alcoholic Steatohepatitis
Happy Mohamed
Wednesday, February 22, 2023
$7M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying
Lisa Levin
Tuesday, February 07, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Tuesday, January 24, 2023
Galectin Therapeutics Contribution To Improve...
Benzinga Newsdesk
Thursday, January 05, 2023
Galectin Therapeutics Announces The End Of En...
Benzinga Newsdesk
Monday, November 14, 2022
Galectin Therapeutics Q3 EPS $(0.14), Same Yo...
Benzinga Newsdesk
Wednesday, October 12, 2022
Galectin Therapeutics Receives FDA Approval To Proceed With Combination Immunotherapy Trial In Head And Neck Cancer
Bill Haddad
Thursday, October 06, 2022
Galectin Therapeutics Reports The Outcome Of ...
Bill Haddad
Thursday, September 29, 2022
CORRECTION: Correct Ticker For Galecto Is 'GL...
Benzinga Newsdesk
Monday, August 15, 2022
Galectin Therapeutics Q2 EPS $(0.16) Down Fro...
Benzinga Newsdesk
Monday, August 01, 2022
Around $30 Million Bet On This Communication Services Stock? 4 Penny Stocks Insiders Are Buying
Lisa Levin
Friday, July 29, 2022
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
Lisa Levin
Wednesday, July 27, 2022
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, June 21, 2022
Galectin Therapeutics Announces 2 Liver Cirrh...
Benzinga Newsdesk
Thursday, June 02, 2022
62 Biggest Movers From Yesterday
Lisa Levin
Tuesday, May 24, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Tuesday, May 17, 2022
HC Wainwright & Co. Maintains Buy on Galectin...
Benzinga Newsdesk
Monday, May 16, 2022
Recap: Galectin Therapeutics Q1 Earnings
Benzinga Insights
Galectin Therapeutics Q1 EPS $(0.17) Down Fro...
Benzinga Newsdesk
Wednesday, May 11, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Wednesday, May 04, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Thursday, April 28, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Thursday, April 14, 2022
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Galectin Therapeutics Reports Outcome Of The ...
Benzinga Newsdesk
Monday, April 04, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, April 01, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, March 31, 2022
Galectin Therapeutics: Q4 Earnings Insights
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
